Device evaluation details: the device was returned to biosense webster inc (bwi) for evaluation.Visual inspection and screening test of the returned device were performed following bwi procedures.Visual analysis revealed reddish material inside the pebax and a hole leaving internal components exposed.The device was connected to carto 3 system and the device was visualized and recognized correctly; however, error 106 appeared on the system due to an open circuit on the tip area.The root cause of pebax cannot be related to the manufacturing process since there is evidence that the device was manufactured in accordance with documented specifications and procedures.However, it could be related to the handling of the device during the procedure, but this cannot be conclusively determined.This issue could be contributed to the force issue reported by the customer.Additionally, a picture was received for evaluation from the customer.According to pictures provided by the customer, reddish material (presumably blood) was observed inside the pebax; however, no external damages were observed on the device.The blood inside the pebax could be related to the force issue reported by the customer; however, this cannot be conclusively determined.A manufacturing record evaluation was performed, and no internal actions related to the reported complaint condition were identified.The issue reported by the customer was confirmed.It should be noted that product failure is multifactorial.As part of biosense webster's quality process, all devices are manufactured, inspected, and released to approved specifications.Explanation of codes: investigation findings: open circuit (c0205)/investigation conclusions: cause not established (d15)/component code: sensor (g03012) were selected as related to the customer reported force issues.Investigation findings: material and/or chemical problem identified (c06)/investigation conclusions: unintended use error caused or contributed to event (d1102)/component code: sleeve (g04115) were selected as related to blood and hole in the pebax.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|